NCT06584838View on ClinicalTrials.gov

Primary ACL Reconstruction in Patient Over 40 Years: Allograft Versus Autograft

Not yet recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

February 28, 2025

Conditions
ACLACL Injury
Interventions
PROCEDURE

ACL reconstruction

Patients that underwent ACL reconstruction using either allograft or autograft tendons, at least 2 years of follow-up, gender male and female, no comorbidities

Trial Locations (1)

20132

IRCCS Ospedale San Raffaele, Milan

All Listed Sponsors
lead

Università Vita-Salute San Raffaele

OTHER

NCT06584838 - Primary ACL Reconstruction in Patient Over 40 Years: Allograft Versus Autograft | Biotech Hunter | Biotech Hunter